menu
    • menu

    Company profile for RVL Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved eyecare product provides the foundation of our unwavering commitment to improve patients’ lives. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying ...
    RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved eyecare product provides the foundation of our unwavering commitment to improve patients’ lives. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RVL PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Crossing Blvd, Bridgewater, New Jersey 08807
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://rvlpharma.com/
    Linkedin
    Linkedin
    https://linkedin.com/company/rvl-pharmaceuticals-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RVL Pharma Appoints Leaders to Accelerate Commercial Growth
    RVL Pharma Appoints Leaders to Accelerate Commercial Growth

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rvl-pharmaceuticals-announces-leadership-appointments-to-accelerate-next-phase-of-growth-and-commercial-momentum-302624110.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Upneeq Wins 2024 Shape Skin
    Upneeq Wins 2024 Shape Skin "Best for Lift" Award

    17 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240517409527/en

    BUSINESSWIRE
    17 May 2024
    Share Share
    RVL Completes Financial Restructuring
    RVL Completes Financial Restructuring

    27 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/27/2786001/0/en/RVL-Completes-Financial-Restructuring.html

    GLOBENEWSWIRE
    27 Nov 2023
    Share Share
    RVL Pharma Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
    RVL Pharma Announces Prepackaged Reorganization of Certain U.S. Subsidiaries

    12 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/12/2759072/0/en/RVL-Pharmaceuticals-plc-Announces-Prepackaged-Reorganization-of-Certain-U-S-Subsidiaries.html

    GLOBENEWSWIRE
    12 Oct 2023
    Share Share
    RVL Pharma to Present at H.C. Wainwright 25th Annual Investment Conference
    RVL Pharma to Present at H.C. Wainwright 25th Annual Investment Conference

    23 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/23/2730719/0/en/RVL-Pharmaceuticals-plc-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    23 Aug 2023
    Share Share
    RVL Pharma Announces $5M Direct Offering Priced At-the-Market under Nasdaq Rules
    RVL Pharma Announces $5M Direct Offering Priced At-the-Market under Nasdaq Rules

    16 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/16/2726275/0/en/RVL-Pharmaceuticals-plc-Announces-5-Million-Registered-Direct-Offering-Priced-At-the-Market-under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    16 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search